Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
52
Views
21
CrossRef citations to date
0
Altmetric
Original Research

LncRNA FOXD2-AS1 Regulates miR-25-3p/Sema4c Axis To Promote The Invasion And Migration Of Colorectal Cancer Cells

Mengyan Zhang1 Department of Oncology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an City, Jiangsu Province 223300, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1715-0887
ORCID Icon,
Xiang Jiang2 Courage Pancreas Surgical, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an City, Jiangsu Province 223300, People’s Republic of China
,
Sumei Jiang3 Ultrasonic Department, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an City, Jiangsu Province 223300, People’s Republic of China
,
Zhongying Guo4 Department of Pathology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an City, Jiangsu Province 223300, People’s Republic of China
,
Qinfeng Zhou5 Department of Laboratory Medicine, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province 215600, People’s Republic of China
&
Jingdong He1 Department of Oncology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an City, Jiangsu Province 223300, People’s Republic of ChinaCorrespondence[email protected]
Pages 10633-10639 | Published online: 19 Dec 2019

References

  • Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10 ):1637–1649. doi:10.1136/gutjnl-2014-30908626041752
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6 ):394–424. doi:10.3322/caac.v68.630207593
  • Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4 ):250–281. doi:10.3322/caac.2145729846947
  • Force USPST, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23 ):2564–2575. doi:10.1001/jama.2016.598927304597
  • Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi RE, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1 ):7–11. doi:10.1007/s13304-016-0359-y27067591
  • Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(4 ):191–197. doi:10.1055/s-0029-124245821037809
  • Jeon J, Du M, Schoen RE, et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology. 2018;154(8 ):2152–2164 e2119. doi:10.1053/j.gastro.2018.02.02129458155
  • Grasso CS, Giannakis M, Wells DK, et al. Genetic mechanisms of immune evasion in colorectal cancer. Cancer Discov. 2018;8(6 ):730–749. doi:10.1158/2159-8290.CD-17-132729510987
  • Bahrami A, Khazaei M, Hasanzadeh M, et al. Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress. J Cell Biochem. 2018;119(3 ):2460–2469. doi:10.1002/jcb.2595028230287
  • Ross JS, Fakih M, Ali SM, et al. Targeting HER2 in colorectal cancer: the landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer. 2018;124(7 ):1358–1373.29338072
  • Song J, Li Y. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells. Cancer Sci. 2017;108(1 ):23–31. doi:10.1111/cas.2017.108.issue-127743413
  • Liu X, Fu Q, Li S, et al. LncRNA FOXD2-AS1 functions as a competing endogenous RNA to regulate TERT expression by sponging miR-7-5p in thyroid cancer. Front Endocrinol (Lausanne). 2019;10:207. doi:10.3389/fendo.2019.0020731024447
  • Yang X, Duan B, Zhou X. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(16 ):3586–3591.28925486
  • Dong H, Cao W, Xue J. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1. Biochem Biophys Res Commun. 2019;508(4 ):1074–1081. doi:10.1016/j.bbrc.2018.12.05030553445
  • Xu JY, Yang LL, Ma C, Huang YL, Zhu GX, Chen QL. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Trop Med. 2013;6(9 ):743–747. doi:10.1016/S1995-7645(13)60130-323827155
  • Chen H, Pan H, Qian Y, Zhou W, Liu X. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2. Mol Cancer. 2018;17(1 ):4. doi:10.1186/s12943-017-0754-029310680

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.